MediFind
Condition

Renal Oncocytoma

Symptoms, Doctors, Treatments, Research & More

Active Clinical Trials

Clinical Trial
Device
  • Status: Not yet recruiting
  • Study Type: Device
  • Participants: 86
  • Start Date: February 2021
Judging MR Simulation Procedures: A Phase I-II Study of the Use of Magnetic Resonance Imaging Simulation in the Planning of Radiation Treatments
Clinical Trial
Drug
  • Status: Not yet recruiting
  • Study Type: Drug
  • Participants: 32
  • Start Date: January 1, 2021
An Adaptive Approach to Neoadjuvant Therapy to Maximize Resection Rates for Pancreatic Adenocarcinoma: A Phase II Trial
Clinical Trial
Behavioral
  • Status: Not yet recruiting
  • Study Type: Behavioral
  • Participants: 1000
  • Start Date: December 1, 2020
Study of Compliance, Practice Patterns, and Barriers REgarding Established National Screening Programs for Barrett's Esophagus: SCREEN-BE
Clinical Trial
Drug
  • Status: Not yet recruiting
  • Study Type: Drug
  • Participants: 18
  • Start Date: December 2020
PLATPARP: A Phase II Single-Arm Trial of Niraparib in Platinum-Sensitive Castration-Resistant Prostate Cancer With DNA Repair Defects
Clinical Trial
Drug
  • Status: Not yet recruiting
  • Study Type: Drug
  • Participants: 105
  • Start Date: November 30, 2020
PIONEER-Panc: Phase II Investigations of New and Emerging Therapies for Pancreatic Cancer
Clinical Trial
Drug
  • Status: Recruiting
  • Study Type: Drug
  • Participants: 165
  • Start Date: November 21, 2020
Fluciclovine (FACBC) PET/CT Site-Directed Therapy of Oligometastatic Prostate Cancer (Flu-BLAST-PC)
Clinical Trial
Drug
  • Status: Not yet recruiting
  • Study Type: Drug
  • Participants: 25
  • Start Date: November 15, 2020
A Phase IIa Study of Rintatolimod Plus Pembrolizumab in Refractory Metastatic Colorectal Cancer
Clinical Trial
Drug
  • Status: Not yet recruiting
  • Study Type: Drug
  • Participants: 35
  • Start Date: November 2020
A Phase II Study of Temozolomide, Cisplatin and Nivolumab in MMR-Proficient Colorectal Cancer
Clinical Trial
Drug
  • Status: Not yet recruiting
  • Study Type: Drug
  • Participants: 24
  • Start Date: October 31, 2020
A Phase 1 Study of NBTXR3 Activated by Radiotherapy With Concurrent Chemotherapy for Adenocarcinoma of the Esophagus
Clinical Trial
Drug
  • Status: Not yet recruiting
  • Study Type: Drug
  • Participants: 36
  • Start Date: October 31, 2020
Phase II Study of Stereotactic Body Radiotherapy and Focal Adhesion Kinase Inhibitor in Advanced Pancreas Adenocarcinoma